http://medicineworld.org/cancer/prostate/prostate-cancer-blog.html Prostate cancer blog from medicineworld.org adds a personal touch to the stories related to prostate cancer. This prostate cancer blog brings you stories of hope, stories of survivors and latest news and research related to prostate cancer. Fri, 02 Jan 2009 15:46:09 GMT en-us http://medicineworld.org/images/blogs/prostate.jpg http://medicineworld.org/cancer/blog/permalinks/Dec-2005/cure-cancer-with-your-personal-computer.html 107 99 http://medicineworld.org/cancer/lead/1-2009/no-impact-on-the-treatment-outcomes.html http://medicineworld.org/cancer/lead/1-2009/no-impact-on-the-treatment-outcomes.html Fri, 02 Jan 2009 15:46:09 GMT In a first of its kind study, a first-degree family history of prostate cancer has no impact on the therapy outcomes of patients with prostate cancer treated with brachytherapy (also called seed implants), and patients with this type of family history have clinical and pathologic characteristics similar to men with no family history at all, as per a January 1 study in the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology........ ]]> http://medicineworld.org/cancer/lead/12-2008/hormonal-therapy-of-prostate-cancer.html http://medicineworld.org/cancer/lead/12-2008/hormonal-therapy-of-prostate-cancer.html Fri, 02 Jan 2009 15:46:09 GMT The hormone deprivation treatment that patients with prostate cancer often take gives them only a temporary fix, with tumors commonly regaining their hold within a couple of years. Now, scientists at Johns Hopkins have discovered critical differences in the hormone receptors on prostate cancer cells in patients who no longer respond to this treatment. The findings, published in the Jan. 1 issue of Cancer Research, could lead to a way to track disease progression, as well as new targets to fight prostate cancer........ ]]> http://medicineworld.org/cancer/lead/12-2008/cough-medicine-prostate-cancer.html http://medicineworld.org/cancer/lead/12-2008/cough-medicine-prostate-cancer.html Fri, 02 Jan 2009 15:46:09 GMT A study published recently in the recent issue of the European medical journal Anticancer Research demonstrates that an ingredient used in a common cough suppressant may be useful in treating advanced prostate cancer. Scientists observed that noscapine, which has been used in cough medicine for nearly 50 years, reduced tumor growth in mice by 60% and limited the spread of tumors by 65% without causing harmful side effects........ ]]> http://medicineworld.org/cancer/lead/12-2008/low-income-men-and-advanced-prostate-cancer.html http://medicineworld.org/cancer/lead/12-2008/low-income-men-and-advanced-prostate-cancer.html Fri, 02 Jan 2009 15:46:09 GMT Low-income men are more likely to present with advanced prostate cancers, most likely because they don't receive screening services shown to reduce the diagnosis of later-stage cancers, a UCLA study found. The study focused on a group of disadvantaged men enrolled in the state's IMPACT (Improving Access, Counseling and Treatment for Californians with Prostate Cancer) program, which provides high-quality care to poor, underinsured and uninsured men. Scientists observed that of the 570 men studied, 19 percent had metastatic cancer at diagnosis, in comparison to 4 percent of men from the general population who were followed in other studies........ ]]> http://medicineworld.org/cancer/lead/12-2008/men-with-wives-more-likely-to-be.html http://medicineworld.org/cancer/lead/12-2008/men-with-wives-more-likely-to-be.html Fri, 02 Jan 2009 15:46:09 GMT Eventhough the link between early screening and prostate cancer survival is well established, men are less likely to go for early screening unless they have a wife or significant other living with them, as per a research studypublished in Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research........ ]]> http://medicineworld.org/cancer/lead/10-2008/prostate-cancer-gene-test.html http://medicineworld.org/cancer/lead/10-2008/prostate-cancer-gene-test.html Fri, 02 Jan 2009 15:46:09 GMT Arnhem, 16 October 2008 Prostate cancer (PCa) is one of the most common male cancers in the Western world. Currently, early detection of PCa depends on an abnormal digital rectal examination and an elevated prostate-specific-antigen (PSA) level requiring a prostate biopsy, often linked to anxiety, discomfort, complications, and heavy expenses. The prostate-cancer-gene-3 (PCA3) test is a new PCa gene-based marker carried out with a urine sample. PCA3 is highly specific to PCa and has shown promising early detection results at repeat biopsy. It may allow patients to avoid unnecessary biopsies. The PCA3 gene is dominant in over 95% of cancerous prostate tissue in comparison to non-malignant and normal prostate tissue........ ]]> http://medicineworld.org/cancer/lead/9-2008/determine-whether-to-treat-prostate-cancer.html http://medicineworld.org/cancer/lead/9-2008/determine-whether-to-treat-prostate-cancer.html Fri, 02 Jan 2009 15:46:09 GMT Concerns regarding the association of hormone treatment used to treat prostate cancer with cardiovascular disease in some older men may lead doctors to forgo hormone therapy solely on the basis of age. But a new study by physicians at Fox Chase Cancer Center shows that men over age 70 with high-risk prostate cancer lived longer and experienced increases in PSA less frequently when treated with long-term androgen deprivation treatment........ ]]> http://medicineworld.org/cancer/lead/9-2008/radiation-plus-hormone-therapy-in-prostate-cancer.html http://medicineworld.org/cancer/lead/9-2008/radiation-plus-hormone-therapy-in-prostate-cancer.html Fri, 02 Jan 2009 15:46:09 GMT Boston For men with locally advanced prostate cancer the addition of radiation therapy to anti-androgen hormone treatment reduces the risk of dying of prostate cancer by 50 percent in comparison to those who have anti-androgen hormone therapy alone, as per a randomized study presented September 22, 2008, at the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting in Boston........ ]]> http://medicineworld.org/cancer/lead/9-2008/painkillers-prostate-cancer-biomarker.html http://medicineworld.org/cancer/lead/9-2008/painkillers-prostate-cancer-biomarker.html Fri, 02 Jan 2009 15:46:09 GMT Common painkillers like aspirin and ibuprofen appear to lower a man's PSA level, the blood biomarker widely used by physicians to help gauge whether a man is at risk of prostate cancer. But the authors of the study, which appears online Sept. 8 in the journal Cancer, caution that men shouldn't take the painkillers in an effort to prevent prostate cancer just yet........ ]]> http://medicineworld.org/cancer/lead/9-2008/too-much-calcium-in-blood-may-increase-risk.html http://medicineworld.org/cancer/lead/9-2008/too-much-calcium-in-blood-may-increase-risk.html Fri, 02 Jan 2009 15:46:09 GMT Men who have too much calcium in their bloodstreams may have an increased risk of fatal prostate cancer, as per a new analysis from Wake Forest University School of Medicine and the University of Wisconsin. "We show that men in upper range of the normal distribution of serum calcium subsequently have an almost three-fold increased risk for fatal prostate cancer," said Gary G. Schwartz, Ph.D., associate professor of cancer biology and of epidemiology and prevention at Wake Forest, a part of Wake Forest University Baptist Medical Center. Such excess calcium can be lowered, he said........ ]]> http://medicineworld.org/cancer/lead/9-2008/height-linked-to-risk-of-prostate-cancer.html http://medicineworld.org/cancer/lead/9-2008/height-linked-to-risk-of-prostate-cancer.html Fri, 02 Jan 2009 15:46:09 GMT A man's height is a modest marker for risk of prostate cancer development, but is more strongly associated with progression of the cancer, say British scientists who conducted their own study on the connection and also evaluated 58 published studies. In the recent issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research, 12 scientists at four universities in England studied more than 9,000 men with and without prostate cancer and estimated that the risk of developing the disease rises by about six percent for every 10 centimeters (3.9 inches) in height a man is over the shortest group of men in the study. That means a man who is one foot taller than the shortest person in the study would have a 19 percent increased risk of developing the disease........ ]]> http://medicineworld.org/cancer/lead/8-2008/health-risk-behaviors-and-psa-awareness.html http://medicineworld.org/cancer/lead/8-2008/health-risk-behaviors-and-psa-awareness.html Fri, 02 Jan 2009 15:46:09 GMT As per a research studyconducted at Columbia University Mailman School of Public Health, health risk behaviors such as smoking and obesity are linked to lower awareness of the Prostate Specific Antigen (PSA), which could lead to a lower likelihood of undergoing actual prostate cancer screening. Eventhough prior studies have explored predictors of PSA test awareness, this is the first research to focus on health risk behaviors, such as smoking, physical inactivity, obesity, and excessive alcohol consumption. The study findings were published in the recent issue of The Journal of Urology....... ]]> http://medicineworld.org/cancer/lead/8-2008/prostate-cancer-ultimately-fails.html http://medicineworld.org/cancer/lead/8-2008/prostate-cancer-ultimately-fails.html Fri, 02 Jan 2009 15:46:09 GMT Some of the drugs given to a number of men during their fight against prostate cancer can actually spur some cancer cells to grow, scientists have found. The findings were published online this week in a pair of papers in the Proceedings of the National Academy of Sciences The results may help explain a phenomenon that has bedeviled patients for decades. Hormone treatment, a common therapy for men with advanced prostate cancer, generally keeps the cancer at bay for a year or two. But then, for reasons researchers have never understood, the therapy fails in patients whose disease has spread the cancer begins to grow again, at a time when patients have few therapy options left........ ]]> http://medicineworld.org/cancer/lead/7-2008/effective-with-hormone-therapy.html http://medicineworld.org/cancer/lead/7-2008/effective-with-hormone-therapy.html Fri, 02 Jan 2009 15:46:09 GMT Among patients with castration-resistant prostate cancer, the addition of hormone treatment following vaccine therapy improved overall survival compared with either therapy alone or when the vaccine followed hormone therapy, as per recent data reported in the July 15 Clinical Cancer Research, a journal of the American Association for Cancer Research........ ]]> http://medicineworld.org/cancer/lead/7-2008/designer-diet-for-prostate-cancer.html http://medicineworld.org/cancer/lead/7-2008/designer-diet-for-prostate-cancer.html Fri, 02 Jan 2009 15:46:09 GMT Eating one or more portions of broccoli every week can reduce the risk of prostate cancer, and the risk of localised cancer becoming more aggressive. For the first time, a research group at the Institute of Food Research led by Professor Richard Mithen has provided an explanation of how eating broccoli might reduce cancer risk based upon studies in men, as opposed to trying to extrapolate from animal models. Prostate cancer is the most common non-skin cancer for males in western countries. The research has provided an insight into why eating broccoli can help men stay healthy........ ]]> http://medicineworld.org/cancer/lead/6-2008/promising-cancer-drug-target-in-prostate-tumors.html http://medicineworld.org/cancer/lead/6-2008/promising-cancer-drug-target-in-prostate-tumors.html Fri, 02 Jan 2009 15:46:09 GMT Researchers at Dana-Farber Cancer Institute report they have blocked the development of prostate tumors in cancer-prone mice by knocking out a molecular unit they describe as a "powerhouse" that drives runaway cell growth. In an article that is being published recently as an advanced online publication by the journal Nature, the scientists say the growth-stimulating molecule called p110beta -- part of a cellular signaling network disrupted in several common cancers -- is a promising target for novel cancer therapies designed to shut it down. The report's lead authors are Shidong Jia, MD, PhD, Zhenning Liu, PhD, Sen Zhang PhD, and Pixu Liu, MD, PhD........ ]]>